358 related articles for article (PubMed ID: 32970276)
1. A Review of Prostanoid Receptors: Expression, Characterization, Regulation, and Mechanism of Action.
Biringer RG
J Cell Commun Signal; 2021 Jun; 15(2):155-184. PubMed ID: 32970276
[TBL] [Abstract][Full Text] [Related]
2. A review of non-prostanoid, eicosanoid receptors: expression, characterization, regulation, and mechanism of action.
Biringer RG
J Cell Commun Signal; 2022 Mar; 16(1):5-46. PubMed ID: 34173964
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of the signaling and trafficking of the two prostaglandin D2 receptors, prostanoid DP receptor and CRTH2.
Gallant MA; Slipetz D; Hamelin E; Rochdi MD; Talbot S; de Brum-Fernandes AJ; Parent JL
Eur J Pharmacol; 2007 Feb; 557(2-3):115-23. PubMed ID: 17207480
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of prostanoid receptors in hepatocytes, Kupffer cells, sinusoidal endothelial cells and stellate cells of rat liver.
Fennekohl A; Schieferdecker HL; Jungermann K; Püschel GP
J Hepatol; 1999 Jan; 30(1):38-47. PubMed ID: 9927149
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal regulation of human platelet function by endogenous prostanoids and through multiple prostanoid receptors.
Hubertus K; Mischnik M; Timmer J; Herterich S; Mark R; Moulard M; Walter U; Geiger J
Eur J Pharmacol; 2014 Oct; 740():15-27. PubMed ID: 25003953
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2-stimulated prostanoid EP4 receptors induce prolonged de novo prostaglandin E2 synthesis through biphasic phosphorylation of extracellular signal-regulated kinases mediated by activation of protein kinase A in HCA-7 human colon cancer cells.
Fujino H; Seira N; Kurata N; Araki Y; Nakamura H; Regan JW; Murayama T
Eur J Pharmacol; 2015 Dec; 768():149-59. PubMed ID: 26518053
[TBL] [Abstract][Full Text] [Related]
7. The constitutive activity of ghrelin receptors is decreased by co-expression with vasoactive prostanoid receptors when over-expressed in human embryonic kidney 293 cells.
Chow KB; Leung PK; Cheng CH; Cheung WT; Wise H
Int J Biochem Cell Biol; 2008; 40(11):2627-37. PubMed ID: 18573679
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes.
Boie Y; Stocco R; Sawyer N; Slipetz DM; Ungrin MD; Neuschäfer-Rube F; Püschel GP; Metters KM; Abramovitz M
Eur J Pharmacol; 1997 Dec; 340(2-3):227-41. PubMed ID: 9537820
[TBL] [Abstract][Full Text] [Related]
9. G protein-coupled prostanoid receptors and the kidney.
Breyer MD; Breyer RM
Annu Rev Physiol; 2001; 63():579-605. PubMed ID: 11181968
[TBL] [Abstract][Full Text] [Related]
10. Multitargeting of selected prostanoid receptors provides agents with enhanced anti-inflammatory activity in macrophages.
Wang JW; Woodward DF; Martos JL; Cornell CL; Carling RW; Kingsley PJ; Marnett LJ
FASEB J; 2016 Jan; 30(1):394-404. PubMed ID: 26420849
[TBL] [Abstract][Full Text] [Related]
11. Eicosanoid receptors: Targets for the treatment of disrupted intestinal epithelial homeostasis.
Moreno JJ
Eur J Pharmacol; 2017 Feb; 796():7-19. PubMed ID: 27940058
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandins and Their Receptors in Eosinophil Function and As Therapeutic Targets.
Peinhaupt M; Sturm EM; Heinemann A
Front Med (Lausanne); 2017; 4():104. PubMed ID: 28770200
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 selectively antagonizes prostaglandin F2alpha-stimulated T-cell factor/beta-catenin signaling pathway by the FPB prostanoid receptor.
Fujino H; Vielhauer GA; Regan JW
J Biol Chem; 2004 Oct; 279(42):43386-91. PubMed ID: 15280380
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of diverse actions of prostanoid receptors.
Negishi M; Sugimoto Y; Ichikawa A
Biochim Biophys Acta; 1995 Oct; 1259(1):109-19. PubMed ID: 7492609
[TBL] [Abstract][Full Text] [Related]
16. Prostanoid receptors: ontogeny and implications in vascular physiology.
Wright DH; Abran D; Bhattacharya M; Hou X; Bernier SG; Bouayad A; Fouron JC; Vazquez-Tello A; Beauchamp MH; Clyman RI; Peri K; Varma DR; Chemtob S
Am J Physiol Regul Integr Comp Physiol; 2001 Nov; 281(5):R1343-60. PubMed ID: 11641101
[TBL] [Abstract][Full Text] [Related]
17. The molecular biology and ocular distribution of prostanoid receptors.
Woodward DF; Regan JW; Lake S; Ocklind A
Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S15-21. PubMed ID: 9154272
[TBL] [Abstract][Full Text] [Related]
18. Prostanoid receptor heterogeneity through alternative mRNA splicing.
Pierce KL; Regan JW
Life Sci; 1998; 62(17-18):1479-83. PubMed ID: 9585122
[TBL] [Abstract][Full Text] [Related]
19. Mucosal prostanoid receptors and synthesis in familial adenomatous polyposis.
Takafuji V; Lublin D; Lynch K; Roche JK
Histochem Cell Biol; 2001 Aug; 116(2):171-81. PubMed ID: 11685545
[TBL] [Abstract][Full Text] [Related]
20. Functional pharmacology of human prostanoid EP2 and EP4 receptors.
Wilson RJ; Rhodes SA; Wood RL; Shield VJ; Noel LS; Gray DW; Giles H
Eur J Pharmacol; 2004 Oct; 501(1-3):49-58. PubMed ID: 15464062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
